From DCAT Value Chain Insights (VCI)
Hovione has appointed Dr. Filipe Gaspar as vice president of its research and development organization. He will lead teams based in Lisbon and New Jersey that serve the company's clients’ drug development projects and will also be defining long-term product development strategies and collaborations. He will report to Guy Villax, Hovione’s chief executive.
Dr. Gaspar is the co-author and co-inventor of numerous publications, scientific presentations and patents. He is a chemical engineer from the Instituto Superior Técnico (Lisbon) and has a PhD in chemical engineering from the University of Birmingham.
Dr. Gaspar joined Hovione in 2003 as a manufacturing engineer and later became responsible for the technical leadership of spray-drying technology. In 2004, he moved to R&D to start the particle engineering group, there he was involved in more than 120 projects from preclinical stage to commercial. During that period he was the lead scientist in four projects that reached commercial stage, including the first at Hovione submitted under Quality by Design. He was instrumental in many of the projects in particle engineering. In 2012, he moved to a business development role and spent a year based in New Jersey.
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription